Hansa Biopharma: Issue and repurchase of class C shares for incentive programs
Lund December 9, 2021. The board of directors of Hansa Biopharma AB (publ) (“Hansa”), (Nasdaq Stockholm: HNSA) today resolved to issue 440,452 new class C shares and to immediately thereafter repurchase such 440,452 issued class C shares. Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on 12 May 2021. Svenska Handelsbanken AB (publ) will subscribe for all issued class C shares at a subscription price of SEK one (1) per share. All 440,452 issued class C shares will be repurchased by Hansa at a purchase price of